부산대학교 도서관

Sainvil, Marie-Michele ; Lowe, Melissa ; Underwood, Delaney ; Li, Yan ; Akinyemiju, Tomi ; Choi, Taewoong ; Gasparetto, Cristina ; Horwitz, Mitchell ; Long, Gwynn D ; Lopez, Richard D ; Sarantopoulos, Stefanie ; Alyea, Edwin P ; Chao, Nelson J. ; LeBlanc, Thomas W. ; Kang, Yubin ; Kirby, Suzanne ; Ramalingam, Sendhilnathan ; Sung, Anthony D ; Hong, Sanghee

In Transplantation and Cellular Therapy February 2025 31(2) Supplement:S344-S345

Infield, Jordan ; Smith, Patrick J ; Merwin, Rhonda M ; Racioppi, Alessandro ; O'Connell, Christine ; Taylor, Allison O. ; Hill, Lauren ; Winthrop, Hilary ; Alyea, Edwin P ; Chao, Nelson J. ; Choi, Taewoong ; Gasparetto, Cristina ; Hong, Sanghee ; Horwitz, Mitchell ; Kang, Yubin ; Long, Gwynn D ; Lopez, Richard D ; Ramalingam, Sendhilnathan ; Sarantopoulos, Stefanie ; Sung, Anthony D

In Transplantation and Cellular Therapy February 2024 30(2) Supplement:S117-S118

Sainvil MM; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina. Electronic address: michele.sainvil@duke.edu.; Artese AL; Department of Exercise Science and Health Promotion, Florida Atlantic University, Boca Raton, Florida; Center for the Study of Aging and Human Development, Duke University School of Medicine, Durham, North Carolina.; Fish LJ; Department of Family Medicine and Community Health, Duke University School of Medicine, and Duke Cancer Institute Behavioral Health and Survey Research core, Durham, North Carolina.; Onyewadume CM; Department of Epidemiology, George Washington University, Milken Institute School of Public Health, Washington, District of Columbia.; Titus J; Department of Internal Medicine, University of Central Florida College of Medicine, Orlando, Florida.; Gecaj S; Department of Exercise Science and Health Promotion, Florida Atlantic University, Boca Raton, Florida.; Hill L; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina.; Somers T; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina.; Matthews A; Duke University Health System Nursing, Durham, North Carolina.; Allen DH; Duke University Health System Nursing, Durham, North Carolina.; Sito E; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina.; Andermann TM; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Rezvani AR; Division of Blood & Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, California.; Choi T; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina.; Horwitz ME; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina.; Lopez RD; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina.; Rizzieri DA; Novant Health, Winston Salem, North Carolina.; Sarantopoulos S; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina.; Chao NJ; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina.; Hong S; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina; Department of Population Health Sciences, School of Medicine, Duke University, Durham, North Carolina.; Sung AD; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina; Center for the Study of Aging and Human Development, Duke University School of Medicine, Durham, North Carolina; Division of Hematologic Malignancies and Cellular Therapy, Kansas University, Kansas City, Kansas.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Lin, Chenyu; Morrison, Laura; Alyea, Edwin P; Choi, Taewoong; Gasparetto, Cristina; Long, Gwynn D; Lopez, Richard D; Rizzieri, David A; Sarantopoulos, Stefanie; Sung, Anthony; Chao, Nelson J.; Galamidi-Cohen, Einat; Schwarzbach, Aurelie; Horwitz, Mitchell E.

In Transplantation and Cellular Therapy March 2022 28(3) Supplement:S250-S251

Sung, Anthony D.; Miller, Hilary M.; Romero, Kristi; MacDonald, Grace; Bohannon, Lauren; Molinger, Jeroen; Ren, Yi; Bush, Amy; Lew, Meagan; Cohen, Harvey J; Pastva, Amy; Jung, Sin-Ho; Shah, Nirmish R; Smith, Patrick J; Wischmeyer, Paul E; Wood, William A; Alyea, Edwin; Choi, Taewoong; Gasparetto, Cristina; Horwitz, Mitchell E.; Long, Gwynn D; Lopez, Richard D; Rizzieri, David A; Sarantopoulos, Stefanie; Sullivan, Keith M; Chao, Nelson J.; Bartlett, David B

In Transplantation and Cellular Therapy March 2021 27(3) Supplement:S436-S437

Racioppi, Alessandro; Dalton, Tara; Ramalingam, Sendhilnathan; Romero, Kristi; Ren, Yi; Bohannon, Lauren; Arellano, Consuelo; Jonassaint, Jude; Miller, Hilary M.; Barak, Ian; Fish, Laura J.; Choi, Taewoong; Gasparetto, Cristina; Long, Gwynn D; Lopez, Richard D; Rizzieri, David A; Sarantopoulos, Stefanie; Horwitz, Mitchell E.; Chao, Nelson J.; Shah, Nirmish R; Sung, Anthony

In Transplantation and Cellular Therapy March 2021 27(3) Supplement:S103-S104

Artese AL; Department of Exercise Science and Health Promotion, Florida Atlantic University, 777 Glades Road, Boca Raton, FL, USA. aartese@fau.edu.; Center for the Study of Aging and Human Development, Duke University School of Medicine, Durham, NC, USA. aartese@fau.edu.; Sainvil M; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.; Fish LJ; Department of Family Medicine and Community Health, Duke University School of Medicine, Durham, NC, USA.; Hill L; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.; Somers T; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.; Matthews A; Duke University Health System Nursing, Durham, NC, USA.; Blazek L; Duke University Health System Nursing, Durham, NC, USA.; Sito E; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.; Andermann T; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA.; Rezvani AR; Division of Blood & Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA, USA.; Choi T; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.; Gasparetto CJ; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.; Horwitz ME; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.; Long GD; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.; Lopez RD; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.; Rizzieri DA; Novant Health, Winston Salem, NC, USA.; Sarantopoulos S; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.; Chao NJ; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.; Allen DH; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.; Hong S; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.; Sung AD; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.

Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

Bergens MA; Duke University School of Medicine, Durham, NC, USA.; Lowder YP; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.; Li Y; Duke Cancer Institute Biostatistics Shared Resource, Duke University, Durham, NC, USA.; Johnson EJ; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.; Winthrop HM; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.; Bush AT; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.; Xiong A; Duke University, Durham, NC, USA.; Hill L; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.; Gorski I; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.; Weaver B; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.; Zafar SY; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.; Alyea EP; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.; Chao NJ; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.; Choi T; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.; Gasparetto C; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.; Hong S; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.; Horwitz ME; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.; Lin C; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.; Long GD; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.; Lopez RD; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.; Ramalingam S; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.; Sarantopoulos S; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.; Sullivan KM; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.; Sung AD; Division of Hematologic Malignancies and Cellular Therapy, University of Kansas Medical Center, Westwood, KS, USA. asung2@kumc.edu.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

Beck, Benjamin ; Lopez, Richard D ; Gillespie, G Yancey ; Kim, Hyung ; Cloud, Gretchen ; Pereboeva, Larisa ; Lamb, Lawrence S., Jr.

In Blood 16 November 2012 120(21):4114-4114

Lopez, Richard D ; Mineishi, Shin; Lamb, Lawrence S., Jr.; Kim, Hyung-Gyoon ; Beck, Benjamin

In Blood 16 November 2012 120(21):839-839

Hussaini SMQ; O'Neal Comprehensive Cancer, University of Alabama at Birmingham, Birmingham, AL.; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD.; Department of Medicine, Duke University School of Medicine, Durham, NC.; Ren Y; Duke Cancer Institute Biostatistics Shared Resource, Durham, NC.; Racioppi A; Department of Medicine, Duke University School of Medicine, Durham, NC.; Lew MV; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC.; Bohannon L; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC.; Johnson E; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC.; Li Y; Duke Cancer Institute Biostatistics Shared Resource, Durham, NC.; Thompson JC; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC.; Henshall B; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC.; Darby M; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC.; Choi T; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC.; Lopez RD; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC.; Sarantopoulos S; Duke Cancer Institute Biostatistics Shared Resource, Durham, NC.; Gasparetto C; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC.; Long GD; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC.; Horwitz ME; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC.; Chao NJ; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC.; Zafar SY; Department of Medicine, Duke University School of Medicine, Durham, NC.; Sung AD; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

Pabon CM; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC, USA. cindy.pabon@duke.edu.; Li Z; Department of Biostatistics and Bioinfomatics, Duke University, Durham, NC, USA.; Hennig T; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC, USA.; de Castro C; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC, USA.; Neff JL; Department of Pathology, Divisions of Hematopathology and Molecular Pathology, Genetics and Genomics, Durham, NC, USA.; Horwitz ME; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC, USA.; LeBlanc TW; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC, USA.; Long GD; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC, USA.; Lopez RD; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC, USA.; Sung AD; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC, USA.; Chao N; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC, USA.; Gasparetto C; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC, USA.; Sarantopoulos S; Adams DB; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC, USA.; Erba H; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC, USA.; Rizzieri DA; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC, USA.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Hussaini, S. M. Qasim; Ren, Yi; Lew, Meagan; Bohannon, Lauren M.; Johnson, Ernaya; Thompson, Jillian; Henshall, Bethany; Darby, Maurisa; Choi, Taewoong; Lopez, Richard D; Sarantopoulos, Stefanie; Gasparetto, Cristina J.; Horwitz, Mitchell; Chao, Nelson Jen An; Zafar, Yousuf; Sung, Anthony Derek

Journal of Clinical Oncology. 2023 Supplement 16, Vol. 41, p7052-7052. 1p.

Maung K; Division of Hematologic Malignancies and Cell Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.; Ramalingam S; Division of Hematologic Malignancies and Cell Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.; Chaudhry M; Department of Radiology, Duke University School of Medicine, Durham, North Carolina, United States of America.; Ren Y; Duke Cancer Institute, Biostatistics Shared Resources, Duke University, Durham, North Carolina, United States of America.; Jung SH; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, United States of America.; Romero K; Division of Hematologic Malignancies and Cell Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.; Corbet K; Division of Hematologic Malignancies and Cell Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.; Chao NJ; Division of Hematologic Malignancies and Cell Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.; Duke Cancer Institute, Duke University, Durham, North Carolina, United States of America.; Choi T; Division of Hematologic Malignancies and Cell Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.; Duke Cancer Institute, Duke University, Durham, North Carolina, United States of America.; Diehl AM; Division of Gastroenterology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.; Diehl L; Division of Hematologic Malignancies and Cell Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.; Duke Cancer Institute, Duke University, Durham, North Carolina, United States of America.; Gasparetto C; Division of Hematologic Malignancies and Cell Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.; Duke Cancer Institute, Duke University, Durham, North Carolina, United States of America.; Horwitz M; Division of Hematologic Malignancies and Cell Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.; Duke Cancer Institute, Duke University, Durham, North Carolina, United States of America.; Long GD; Division of Hematologic Malignancies and Cell Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.; Duke Cancer Institute, Duke University, Durham, North Carolina, United States of America.; Lopez RD; Division of Hematologic Malignancies and Cell Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.; Duke Cancer Institute, Duke University, Durham, North Carolina, United States of America.; Rizzieri DA; Division of Hematologic Malignancies and Cell Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.; Duke Cancer Institute, Duke University, Durham, North Carolina, United States of America.; Sarantopoulos S; Division of Hematologic Malignancies and Cell Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.; Duke Cancer Institute, Duke University, Durham, North Carolina, United States of America.; Sullivan KM; Division of Hematologic Malignancies and Cell Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.; Duke Cancer Institute, Duke University, Durham, North Carolina, United States of America.; Bashir MR; Department of Radiology, Duke University School of Medicine, Durham, North Carolina, United States of America.; Sung AD; Division of Hematologic Malignancies and Cell Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.; Duke Cancer Institute, Duke University, Durham, North Carolina, United States of America.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Kanda, Junya; Lopez, Richard; Rizzieri, David; Lopez, Richard D; Rizzieri, David A

International Journal of Hematology; May2011, Vol. 93 Issue 5, p586-593, 8p

Liu, Zhiyong; Guo, Ben; Lopez, Richard D

Journal of Gastroenterology and Hepatology. May 01, 2009 24(5):900-911

Lew MV; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Ren Y; Duke Cancer Institute Biostatistics Shared Resources, Durham, North Carolina.; Lowder YP; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Siamakpour-Reihani S; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Ramalingam S; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Romero KM; Duke University School of Medicine, Durham, North Carolina.; Thompson JC; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Bohannon LM; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; McIntyre J; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Tang H; Duke University School of Medicine, Durham, North Carolina.; Van Opstal J; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina; Faculty of Medicine, KU Leuven, Leuven, Belgium.; Johnson E; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Cohen HJ; Claude D. Pepper Older Americans Independence Center, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina.; Bartlett DB; Claude D. Pepper Older Americans Independence Center, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina; School of Biosciences and Medicine, University of Surrey, Surrey, United Kingdom.; Pastva AM; Claude D. Pepper Older Americans Independence Center, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina; Department of Orthopedic Surgery, Division of Physical Therapy, Duke University Medical Center, Durham, North Carolina.; Morey M; Claude D. Pepper Older Americans Independence Center, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina; Geriatric Research, Education and Clinical Center, Durham VA Healthcare System, Durham, North Carolina.; Hall KS; Claude D. Pepper Older Americans Independence Center, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina; Geriatric Research, Education and Clinical Center, Durham VA Healthcare System, Durham, North Carolina.; Smith P; Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina.; Peters KB; Departments of Neurology and Neurosurgery, The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.; Somers TJ; Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina.; Kelleher S; Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina.; Smith SK; School of Nursing, Duke University Medical Center, Durham, North Carolina.; Wischmeyer PE; Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.; Lin PH; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina.; Wood WA; Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Thorpe G; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Minor K; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Wiggins K; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Hennig T; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Helms T; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Welch R; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Matthews B; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Liu J; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Burleson J; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Aberant T; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Engemann AK; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Henshall B; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Darby M; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Proch C; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Dellascio M; Duke Health Department of Physical Therapy and Occupational Therapy, Durham, North Carolina.; Pittman A; Duke Health Department of Physical Therapy and Occupational Therapy, Durham, North Carolina.; Suminguit J; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Choi T; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Gasparetto C; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, North Carolina.; Long GD; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, North Carolina.; Lopez RD; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Sarantopoulos S; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Horwitz ME; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, North Carolina.; Chao NJ; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, North Carolina.; Sung AD; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina; Claude D. Pepper Older Americans Independence Center, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina. Electronic address: anthony.sung@duke.edu.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Sung AD; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina. Electronic address: anthony.sung@duke.edu.; Giri VK; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina; Stanford Department of Internal Medicine, Stanford, California.; Tang H; Duke University School of Medicine, Durham, North Carolina.; Nichols KR; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina.; Lew MV; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.; Bohannon L; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.; Ren Y; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.; Jung SH; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina.; Dalton T; Duke University School of Medicine, Durham, North Carolina.; Bush A; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.; Van Opstal J; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.; Artica A; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.; Messina J; Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina.; Shelby R; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina.; Frith J; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.; Lassiter M; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina; Clinical Nurse Specialist, Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Burleson J; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.; Leonard K; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.; Potter AS; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.; Choi T; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.; Gasparetto CJ; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.; Horwitz ME; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.; Long GD; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.; Lopez RD; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.; Sarantopoulos S; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.; Chao NJ; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Islam P; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Tang H; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Jin H; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Cao F; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Bohannon LM; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Ren Y; Duke Cancer Institute, Biostatistics Shared Resources, Duke University, Durham, North Carolina.; Chao NJ; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Choi T; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Gasparetto C; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Horwitz ME; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Long GD; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Lopez RD; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Rizzieri DA; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Sarantopoulos S; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Sung AD; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina. Electronic address: anthony.sung@duke.edu.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Giri VK; Duke University School of Medicine, Durham, North Carolina; Stanford Department of Internal Medicine, Stanford, California. Electronic address: vgiri@stanford.edu.; Kegerreis KG; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Ren Y; Duke Cancer Institute Biostatistics Shared Resources, Duke University Medical Center, Durham, North Carolina.; Bohannon LM; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Lobaugh-Jin E; Department of Infection Prevention and Hospital Epidemiology, Duke University Medical Center, Durham, North Carolina.; Messina JA; Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina.; Matthews A; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Mowery YM; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.; Sito E; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Lassiter M; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Saullo JL; Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina.; Jung SH; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina.; Ma L; Department of Statistical Science, Duke University, Durham, North Carolina.; Greenberg M; Department of Statistical Science, Duke University, Durham, North Carolina.; Andermann TM; Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; van den Brink MRM; Department of Medicine and Department of Immunology, Weill Cornell Medical College, New York, New York; Adult Bone Marrow Transplantation service, Memorial Sloan Kettering Cancer Center, New York, New York.; Peled JU; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.; Gomes ALC; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York.; Choi T; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Gasparetto CJ; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Horwitz ME; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Long GD; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Lopez RD; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Rizzieri DA; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Sarantopoulos S; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Chao NJ; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.; Allen DH; Duke University Health System Nursing, Durham, North Carolina.; Sung AD; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina. Electronic address: anthony.sung@duke.edu.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE